Of the clinical parameters, the difference between study groups (normal liver, simple steatosis and NASH) in fasting insulin level at baseline was highly significant mainly due to high insulin level in the NASH group (Table 1). This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.